Open original FDA record ↗Recall record
- FDA identifier
- Z-0397-05
- Company in FDA record
- Baxter Healthcare Renal Div
- FDA classification date
- Jan 15, 2005
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
A software anomaly may allow concentrated solution to be infused into the patient when the HomeChoice unit is used with Physioneal Clear-Flex PD products.
Source facts
- Action
- Baxter notified the Danish Ministry of Health of the problem with the HomeChoice Pro not prompting the patient when using the Physioneal Clear-Flex PD products on 12/23/04. The patients in Denmark and Sweden will be re-evaluate and re-train each patient as needed using enhanced training materials, which will include the importance of and the rationales for breaking the peel-seal on teh Physioneal ClearFlex prior to use and what to do if mis-infusion occurs. Larger, adhesive, colored stickers will be affixed to all applicable HomeChoice Pro machines to further remind patients of the need to break all peel-seals prior to use. Patients will receive a new Pro-Card when their machine is exchanged, and the exchange will be documented. The HomeChoice Pro software will be updated to correct the software anomaly, validated and installed on the HomeChoice Pro machines.
- Initiated
- 2004-12-23
- Root cause
- Other
- Terminated
- 2007-12-11
- Distribution
- Those HomeChoice units in Denmark and Sweden only, where the Physioneal Clear-Flex products are approved for use.
- Recall number
- Z-0397-05
- Recall status
- Terminated
- CDRH record ID
- 36407
- FDA classified
- 2005-01-15
- Recall event number
- 30693